Chime Financial, Inc. (CHYM) Stock Price & Analysis
Chime Financial, Inc. (CHYM) closed at USD 30.16 on Thursday, October 22, 2026, down 0.69% on the day. The US market is currently closed (pre-market); this is not a live price.
The prior close was USD 30.37; the Oct 22, 2026 session ranged USD 29.6–30.73 on volume of 2,091,798 shares. Market capitalization is $11.42B, with a 52-week range of USD 15.88–35.55 (NMS). Source: Nexqual, retrieved October 23, 2026 at 09:12 UTC.
Also available as compact Markdown for AI agents: nexqual.com/CHYM.md
Key facts (CHYM)
- Last four reported quarters (through Jun 30, 2026): revenue $2.46B, net income -$18.2M (-0.7% margin) (SEC filings).
- 3 of 80 tracked superinvestors hold CHYM (13F, Q2 2026): 0 new, 1 added, 2 reduced, 0 unchanged.
- Insider open-market sales, last ~7 months: 38 Form 4 filings, $1.16B; 26 not under a Rule 10b5-1 plan ($1.12B); 0 by opportunistic insiders, 0 by routine insiders (three-year test, Cohen, Malloy & Pomorski 2012).
- Analysts: Buy (mean 1.78 on a 1–5 scale) (23 analysts), mean target USD 39.55 (range 31–50).
- Total return with dividends: 1Y +65.9% vs S&P 500 +14.9%; 5Y -13.3% vs S&P 500 +80.3%.
- Next earnings: 2026-11-04, EPS estimate USD 0.1, revenue estimate $704M.
Financials (SEC 10-K; TTM = last four 10-Q/10-K quarters) (CHYM)
| USD | FY2023 | FY2024 | FY2025 | TTM |
|---|---|---|---|---|
| Revenue | $1.28B | $1.67B | $2.19B | $2.46B |
| Gross profit | $1.06B | $1.47B | $1.92B | — |
| Operating income | -$236M | -$62.2M | -$1.04B | -$51.0M |
| Net income | -$203M | -$25.3M | -$1.01B | -$18.2M |
| EPS (diluted) | -$3.22 | -$0.39 | -$4.27 | — |
| Free cash flow | -$167M | $59.3M | $32.9M | $312M |
| Gross margin | 82.8% | 87.6% | 88.0% | — |
| Operating margin | -18.4% | -3.7% | -47.6% | -2.1% |
| Net margin | -15.9% | -1.5% | -46.2% | -0.7% |
| Revenue growth | — | +30.9% | +30.7% | — |
| Cash + short-term investments | $240M | $707M | $1.05B | — |
Fiscal years end Dec. EPS is split-adjusted.
Valuation (price ÷ last four quarters, through Jun 30, 2026) (CHYM)
P/S 4.7x · P/FCF 36.6x · P/B 8.1x · FCF yield 2.73% · Earnings yield -0.16% · Buyback yield (TTM) 2.62%
Superinvestors (SEC 13F-HR, Q2 2026) (CHYM)
3 of 80 tracked investors hold CHYM. Each row is the investor's latest 13F; change is vs their prior-quarter share count.
| Investor | Firm | % of portfolio | Value | Change |
|---|---|---|---|---|
| Samantha McLemore | Patient Capital Management | 2.78% | $83.6M | Added +41.6% |
| Chase Coleman | Tiger Global Management | 0.45% | $108M | Reduced -52.3% |
| Christopher Davis | Davis Advisors | 0.21% | $47.8M | Reduced -8.2% |
Insider sales (SEC Form 4, open-market, last ~7 months) (CHYM)
12 of 38 under a Rule 10b5-1 trading plan (scheduled in advance). Unplanned sales were timed by the insider.
| Trade date | Insider | Role | Shares | Value | % of holdings sold | 10b5-1 plan | Insider type |
|---|---|---|---|---|---|---|---|
| 2026-10-20 | King Ryan A | Co-Founder | 11,318 | $351K | 6.8% | Yes (adopted August 28, 2025) | Too little history (no open-market trades in 2023–2025) |
| 2026-10-09…2026-10-13 | King Ryan A | Co-Founder | 50,300 | $1.5M | 20.8% | Yes (adopted August 28, 2025) | Too little history (no open-market trades in 2023–2025) |
| 2026-09-14…2026-09-16 | Feuille James | Director | 447,637 | $14.7M | 2.3% | No | Too little history (no open-market trades in 2023 or 2024) |
| 2026-09-15 | Frankel Adam B | General Counsel | 102,002 | $3.4M | 21.8% | Yes (adopted June 16, 2026) | Too little history (no open-market trades in 2023 or 2024) |
| 2026-09-14 | Dst Global Advisors Ltd | 3,216,189 | $109M | 8.2% | No | Too little history (no open-market trades in 2023–2025) | |
| 2026-09-14 | Dst Global Advisors Ltd | 3,216,189 | $109M | 8.2% | No | Too little history (no open-market trades in 2023–2025) | |
| 2026-09-11 | Dst Global Advisors Ltd | 207,513 | $6.9M | 0.5% | No | Too little history (no open-market trades in 2023–2025) | |
| 2026-09-11 | Dst Global Advisors Ltd | 207,513 | $6.9M | 0.5% | No | Too little history (no open-market trades in 2023–2025) | |
| 2026-09-10…2026-09-11 | Carolan Shawn T | Director | 579,313 | $19.2M | 6.2% | No | Too little history (no open-market trades in 2023–2025) |
| 2026-09-10…2026-09-11 | Feuille James | Director | 351,890 | $11.6M | 1.7% | No | Too little history (no open-market trades in 2023 or 2024) |
| 2026-09-11 | Marshall Cynthia | Director | 20,000 | $662K | 40.9% | No | Too little history (no open-market trades in 2023 or 2024) |
| 2026-09-09 | Dst Global Advisors Ltd | 59,630 | $2.1M | 0.2% | No | Too little history (no open-market trades in 2023–2025) | |
| 2026-09-09 | Dst Global Advisors Ltd | 59,630 | $2.1M | 0.2% | No | Too little history (no open-market trades in 2023–2025) | |
| 2026-09-09 | King Ryan A | Co-Founder | 42,421 | $1.5M | 26.7% | Yes (adopted August 28, 2025) | Too little history (no open-market trades in 2023–2025) |
| 2026-09-08 | Asmerom Amine | Chief Accounting Officer | 19,505 | $643K | 6.5% | Yes (adopted December 4, 2025) | Too little history (no open-market trades in 2023 or 2024) |
| 2026-09-01 | Britt Christopher R | Chief Executive Officer | 200,000 | $6.4M | 45.9% | Yes (adopted September 15, 2025) | Too little history (no open-market trades in 2023–2025) |
| 2026-08-28 | Britt Christopher R | Chief Executive Officer | 100,000 | $3.4M | 29.8% | Yes (adopted September 15, 2025) | Too little history (no open-market trades in 2023–2025) |
| 2026-08-26 | Dst Global Advisors Ltd | 1,168,667 | $38.6M | 2.9% | No | Too little history (no open-market trades in 2023–2025) | |
| 2026-08-26 | Dst Global Advisors Ltd | 1,168,667 | $38.6M | 2.9% | No | Too little history (no open-market trades in 2023–2025) | |
| 2026-08-24…2026-08-25 | Dst Global Advisors Ltd | 1,855,958 | $61.4M | 4.4% | No | Too little history (no open-market trades in 2023–2025) |
% of holdings sold = shares sold ÷ (shares sold + all holdings the insider reported on that Form 4, direct and through trusts).
Insider type follows Cohen, Malloy & Pomorski (Journal of Finance, 2012). An insider who traded the stock in the same calendar month in each of the past three years is a routine trader; one who traded in each of those years without such a pattern is an opportunistic trader. In their study, trades by opportunistic insiders predicted future returns and trades by routine insiders did not. Counts open-market purchases and sales only (SEC Form 4 codes P and S) by that insider in that company. Not investment advice.
Analysts (CHYM)
Consensus Buy (mean 1.78 on a 1–5 scale), 23 analysts; mean target USD 39.55 (low 31, high 50).
Rating changes, last 120 days:
| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| 2026-10-08 | Deutsche Bank | Upgrade | Hold → Buy | $30 → $35 |
| 2026-09-15 | Goldman Sachs | Target raised | Buy | $33 → $37 |
| 2026-09-14 | B. Riley Securities | Target raised | Buy | $37 → $44 |
| 2026-09-14 | Rothschild & Co | Upgrade | Neutral → Buy | $46 |
| 2026-09-09 | Loop Capital | Initiated | Buy | $45 |
| 2026-09-09 | Scotiabank | Target raised | Sector Outperform | $40 → $42 |
| 2026-09-09 | UBS | Target raised | Neutral | $28 → $31 |
| 2026-09-09 | Morgan Stanley | Target raised | Overweight | $39 → $40 |
| 2026-09-09 | Piper Sandler | Target raised | Overweight | $35 → $40 |
| 2026-09-09 | Evercore ISI Group | Target raised | Outperform | $39 → $42 |
| 2026-09-09 | Barclays | Target raised | Overweight | $33 → $40 |
| 2026-09-09 | Keybanc | Target raised | Overweight | $33 → $40 |
Total return (dividends reinvested) (CHYM)
| 1Y (from 2025-10-23) | 5Y (from 2025-06-09) | |
|---|---|---|
| Total return | +65.9% | -13.3% |
| S&P 500 (SPY) | +14.9% | +80.3% |
| Per year | +66.2% | -9.9% |
| Volatility (annualized) | 62.4% | 63.2% |
| Max drawdown | -41.1% (Jan 2026→Jun 2026) | -52.0% (Jun 2025→Jun 2026) |
CHYM revenue by product line (quarter ended Jun 30, 2026)
| Line | Revenue | Share of total | YoY |
|---|---|---|---|
| Payments revenue | $430.0M | 64.2% | +17.5% |
| Platform-related revenue | $239.7M | 35.8% | +47.9% |
| MyPay | $114.8M | 17.1% | +47.7% |
| Total revenue | $669.8M | 100% | — |
As tagged by the company in its SEC 10-Q / 10-K filings (XBRL).
CHYM suppliers, customers and competitors (named in its 10-K)
| Relationship | Company | Sentence in the filing |
|---|---|---|
| Partner | Federal Deposit Insurance | “Through our direct relationships with FDIC-insured bank partners, we deliver easy-to-use products that address the most critical financial needs of everyday people — spending, saving, accessing liquidity, and building credit, all while avoiding punitive fees.” |
| Partner | Visa (V) | “Checking accounts are complemented by Chime Debit Cards, which are Visa-branded debit cards issued by our bank partners.” |
| Partner | TabaPay | “ATM access for our members is provided by Allpoint, MoneyPass, and Visa Plus Alliance, each a third-party provider of ATM services; outbound instant transfers are processed by TabaPay, Inc., a third-party instant money movement platform; and we currently host our platform and support our operations using Amazon Web Services, a third-party provider of cloud infrastructure services.” |
| Partner | Amazon (AMZN) | “ATM access for our members is provided by Allpoint, MoneyPass, and Visa Plus Alliance, each a third-party provider of ATM services; outbound instant transfers are processed by TabaPay, Inc., a third-party instant money movement platform; and we currently host our platform and support our operations using Amazon Web Services, a third-party provider of cloud infrastructure services.” |
| Partner | Morgan Stanley Senior Funding | “We have entered into, and may continue to enter into, arrangements pursuant to which we may incur significant indebtedness, including our credit agreement with Morgan Stanley Senior Funding, Inc., as the administrative agent, the collateral agent, a letter of credit issuer and a lender, First-Citizens Bank & Trust Company, as a letter of credit issuer and a lender, and Goldman Sachs Lending Partners LLC, JPMorgan …” |
| Partner | Goldman Sachs Lending Partners | “We have entered into, and may continue to enter into, arrangements pursuant to which we may incur significant indebtedness, including our credit agreement with Morgan Stanley Senior Funding, Inc., as the administrative agent, the collateral agent, a letter of credit issuer and a lender, First-Citizens Bank & Trust Company, as a letter of credit issuer and a lender, and Goldman Sachs Lending Partners LLC, JPMorgan …” |
| Partner | MUFG Bank | “We have entered into, and may continue to enter into, arrangements pursuant to which we may incur significant indebtedness, including our credit agreement with Morgan Stanley Senior Funding, Inc., as the administrative agent, the collateral agent, a letter of credit issuer and a lender, First-Citizens Bank & Trust Company, as a letter of credit issuer and a lender, and Goldman Sachs Lending Partners LLC, JPMorgan …” |
| Partner | Deutsche Bank | “We have entered into, and may continue to enter into, arrangements pursuant to which we may incur significant indebtedness, including our credit agreement with Morgan Stanley Senior Funding, Inc., as the administrative agent, the collateral agent, a letter of credit issuer and a lender, First-Citizens Bank & Trust Company, as a letter of credit issuer and a lender, and Goldman Sachs Lending Partners LLC, JPMorgan …” |
| Competitor | PayPal (PYPL) | “We also face competition from financial technology companies that offer or facilitate bank accounts, payments, and liquidity services, including Affirm, Klarna, and PayPal, and offerings such as Cash App.” |
Quoted from the company's 10-K filed Mar 6, 2026.
CHYM company outlook (results filed Aug 5, 2026)
- “We are raising our full-year 2026 guidance based on second-quarter performance.”
- “For the full year of 2026, we now expect: • Revenue between $2.725 and $2.745 billion, representing year-over-year revenue growth between 25% and 26%. • Adjusted EBITDA between $465 and $475 million, with an adjusted EBITDA margin of 17%, representing an incremental adjusted EBITDA margin of approximately 63%.”
- “For the third quarter of 2026, we expect: • Revenue between $680 and $690 million, resulting in year-over-year revenue growth between 25% and 27%. • Adjusted EBITDA between $105 and $110 million, with an adjusted EBITDA margin between 15% and 16%.”
Quoted word-for-word from the SEC 8-K results press release.
CHYM analyst estimates and revisions
| Period | EPS estimate | 90 days ago | Change | Revenue estimate | Analysts |
|---|---|---|---|---|---|
| Current quarter (ends Sep 2026) | $0.10 | $0.06 | +65.1% | $704.1M | 16 |
| Next quarter (ends Dec 2026) | $0.16 | $0.14 | +16.1% | $747.8M | 16 |
| Current fiscal year (ends Dec 2026) | $0.46 | $0.33 | +42.4% | $2.77B | 18 |
| Next fiscal year (ends Dec 2027) | $0.93 | $0.76 | +22.3% | $3.36B | 16 |
CHYM options: expected move
Options price a move of about ±13.8% (±$4.15) by Nov 20, 2026, which includes earnings on Nov 4, 2026. Over the last 5 reports the stock moved ±13.3% on average.
| Expiration | Days | ATM implied volatility | Expected move |
|---|---|---|---|
| Nov 20, 2026 | 28 | 61.3% | ±13.8% |
| Dec 18, 2026 | 56 | 55.7% | ±17.5% |
| Jan 15, 2027 | 84 | 53.0% | ±20.3% |
| Mar 19, 2027 | 147 | 54.7% | ±27.5% |
| May 21, 2027 | 210 | 54.1% | ±32.3% |
| Jun 17, 2027 | 237 | 55.5% | ±35.1% |
| Aug 20, 2027 | 301 | 56.5% | ±40.1% |
| Nov 19, 2027 | 392 | 56.6% | ±45.6% |
30-day implied volatility 59.5% vs 45.7% realized over the last 30 trading days. Put/call ratio (volume) 0.33. Cboe delayed quotes (15 min). Expected move = at-the-money straddle.
Key Statistics (as of October 23, 2026 at 09:12 UTC)
| Price | USD 30.16 |
|---|---|
| Change | ▼ 0.69% (down) |
| Previous Close | USD 30.37 |
| Open | USD 29.97 |
| Day Range | USD 29.6 – 30.73 |
| 52-Week Range | USD 15.88 – 35.55 |
| Volume | 2,091,798 shares |
| Market Cap | $11.42B |
| Exchange | NMS |
Technical Analysis (CHYM)
Nexqual's technical model rates CHYM "BUY" based on 4 bullish and 1 bearish signals across 127 daily candles, as of October 23, 2026 at 09:12 UTC.
| Overall Signal | BUY |
|---|---|
| RSI (14) | 49.6 (neutral) |
| vs SMA50 | Below (USD 30.68) |
| MACD | 0.17 (positive) |
Analyst Ratings (CHYM)
Wall Street analysts rate CHYM "Buy" based on 23 analysts, with a mean price target of USD 39.55 (range USD 31–50), per Nexqual as of October 23, 2026 at 09:12 UTC.
| Consensus Rating | Buy |
|---|---|
| Analyst Count | 23 |
| Mean Target | USD 39.55 |
| High Target | USD 50 |
| Low Target | USD 31 |
| Buy / Hold / Sell | 22 / 1 / 0 |
Earnings (CHYM)
| Next Earnings Date | 2026-11-04 |
|---|---|
| Revenue Estimate | $704.08M |
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2026-06-30 | USD 0.07 vs est 0.02 ▲ beat |
| 2026-03-31 | USD 0.13 vs est 0.03 ▲ beat |
| 2025-12-31 | USD -0.12 vs est -0.18 ▲ beat |
| 2025-09-30 | USD -0.15 vs est -0.24 ▲ beat |
Source: Nexqual, October 23, 2026 at 09:12 UTC.
Financials & Fundamentals (CHYM)
| Total Revenue | $2.46B |
|---|---|
| Revenue Growth (latest quarter, YoY) | +26.80% |
| Gross Margin | +88.71% |
| Operating Margin | +18.61% |
| Profit Margin | -0.74% |
| ROE | -1.28% |
| Debt / Equity | 0.13 |
| Current Ratio | 4.62 |
| Total Cash | $1.16B |
| Total Debt | $180.88M |
Source: Nexqual, October 23, 2026 at 09:12 UTC.
Financial Health Score (CHYM)
Nexqual rates Chime Financial, Inc.'s overall financial health "Weak" across five dimensions, as of October 23, 2026 at 09:12 UTC.
| Growth | Strong — Revenue +27% YoY (latest Q) |
|---|---|
| Profitability | Critical — Net margin -46% (last 12 months); banks have no gross margin |
| Balance Sheet | N/A — Not comparable for banks: deposits and customer funds sit on the balance sheet, so cash vs debt does not measure safety (SEC industry: Finance Services) |
| Cash Flow | N/A — Not meaningful for banks and lenders: lending and trading move operating cash flow by billions each year (SEC industry: Finance Services) |
| Efficiency | Critical — ROE -1%, ROA 12.0% |
Ownership (CHYM)
| Insider Ownership | +7.60% |
|---|---|
| Institutional Ownership | +95.58% |
| Shares Outstanding | 347.02M |
| Float | 242.13M |
| Short % of Float | +8.94% |
Source: Nexqual, October 23, 2026 at 09:12 UTC.
Leadership (CHYM)
Chime Financial, Inc. is led by Christopher R. Britt, Co-Founder, CEO & Chairperson, per Nexqual as of October 23, 2026 at 09:12 UTC.
| Co-Founder, CEO & Chairperson | Christopher R. Britt |
|---|---|
| President & Interim CFO | Mark T. Troughton |
| Co-Founder & Director | Ryan A. King |
| Chief Operating Officer | Janelle Sallenave |
| Chief Technology Officer | Jeff Currier |
Major Backers & Investors (CHYM)
Notable institutional backers of Chime Financial, Inc. include Galileo (ptc) Ltd, Crosslink Capital Inc, General Atlantic, L.P., according to Nexqual as of October 23, 2026 at 09:12 UTC.
Active Investors
| Investor | Stake |
|---|---|
| Galileo (ptc) Ltd | 15.06% |
| Crosslink Capital Inc | 7.55% |
| General Atlantic, L.P. | 6.13% |
| Menlo Ventures Management, L.P. | 5.03% |
| Aspect Management, LLC | 3.44% |
| Forerunner Ventures Management, LLC | 2.31% |
| Capital Group | 1.63% |
| Advisor Managed Portfolios-Patient Opportunity Trust | 0.89% |
Index Funds (Passive)
| Fund | Stake |
|---|---|
| Vanguard Group | 5.6% |
| BlackRock | 3.24% |
Source: Nexqual, October 23, 2026 at 09:12 UTC.
From Chime Financial, Inc.'s Latest SEC 10-K Filing (filed 2026-03-06)
Key Strengths & Strategy (as disclosed to the SEC)
- Our proprietary technology platform and our digital-first approach give us both a radical cost-to-serve advantage and greater innovation velocity compared to traditional banks.
- We built our proprietary, cloud-native technology platform in-house to drive product innovation and scale.
- Bancorp and Stride are chartered as national banks and subject to regulation and supervision by the Office of the Comptroller of the Currency ("OCC"), as well as subject to other regulations including those promulgated by the Financial Crimes Enforcement Network ("FinCEN"), Federal Deposit Insurance Corporation ("FDIC"), the Federal Reserve, and the Consumer Financial Protection Bureau ("CFPB").
- The liquidity products we offer through our platform, including SpotMe, MyPay, and Instant Loans, provide our eligible members access to short-term liquidity when they need it most for free or at a low cost.
Partnerships
- For too long, millions of Americans, including the nearly 75% of the adult population that earn up to $100,000 annually, have struggled with bank relationships that are not always aligned with their best interests.
- In the United States, 196 million people — nearly 75% of the adult population — earn up to $100,000 annually.
Legal & Regulatory Risks (Item 1A, quoted)
- Our business is subject to a wide range of complex and evolving laws and regulations, which are subject to change and to uncertain interpretation, and failure by us or by our bank partners or third-party service providers to comply with such laws and regulations may adversely affect our business, financial condition, and results of operations.
- We are subject to risks related to the banking ecosystem, including through our bank partnerships, FDIC regulations and policies, and other regulatory obligations, which may adversely affect our business, financial condition, and results of operations.
- The CFPB has significant authority to regulate consumer financial services, and there is uncertainty as to how the agency's actions or the actions of any other agency may impact our business.
- We have been subject to litigation and regulatory investigations, actions, and settlements, and we expect to continue to be subject to such proceedings in the future, which may cause us to incur substantial costs or require us to change our business practices in a manner adverse to our business.
Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| GRAB | Grab Holdings Limited | USD 2.85 | ▲ 1.06% |
| BSY | Bentley Systems, Incorporated | USD 39.41 | ▲ 2.74% |
| PAYC | Paycom Software, Inc. | USD 272.61 | ▲ 4.44% |
| FROG | JFrog Ltd. | USD 93.89 | ▼ 2.5% |
| FIG | Figma, Inc. | USD 24.1 | ▲ 4.87% |
| ESTC | Elastic N.V. | USD 98.21 | ▼ 0.61% |
Data source: Nexqual — market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: October 23, 2026 at 09:12 UTC. This page is informational and not investment advice.
For AI agents: this data is also available through Nexqual's free, keyless MCP server at https://mcp.nexqual.com/mcp; every result includes source_url, as_of and cite_as. More: nexqual.com/agents · llms.txt